AstraZeneca Pharma India Limited Share Price and Company Fundamentals
Last traded: Yesterday at 9:59 AM
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes. The company serves distributors, hospitals, and government institutions. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Key Metrics
PE ratio
99.99
PB ratio
19.38
Dividend yield
0.53%
Beta
0.22
Market cap
₹169.11B
Enterprise value
₹165.74B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 600 |
| Website | https://www.astrazeneca.in |
| Mailing address | Manyata Embassy Business Park Block N1, 12th Floor Rachenahalli Outer Ring Road Bengaluru 560045 India |
| Phone / Fax | 91 80 6774 8000 / 91 80 6774 8857 |
Dividends
Dividend yield
0.53%
Dividend amount
₹36.00
Payout ratio
47.17%
5Y Avg. yield
-%
AstraZeneca Pharma India Limited paid ₹36.00 dividend and the ex-dividend date was 31 Jul 2026.The dividend payout ratio is 47.17%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ASTRAZEN dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Sep 2026, following are the company executives and directors listed on AstraZeneca Pharma India Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Praveen Rao Akkinepally | MD, Country President & Executive Director | ||
| Ms. Tanya Sanish | Company Secretary & Compliance Officer | ||
| Ms. Sandhya Amanna Tejaswini | Director of Legal | ||
| Ms. Smita Saha | Vice President of Human Resources | 55 | |
| Mr. Ayush Kumar Agarwal | Business Unit Head of Biopharmaceutical Business Unit | ||
| Mr. Vinay Sharma | Business Unit Head of Rare Disease unit | ||
| Mr. Natarajan Venkatakrishnan | Head of Market Access | ||
| Ms. Amarpreet Kaur Ahuja | Country HR Director | ||
| Mr. Mr. Srikanth B. S. | Site Lead, India Operations | ||
| Ms. Shikha Mirchandani Chatrath | Director of Commercial Excellence, BD & Strategy |
Profitability and management effectiveness
Profit margin
6.97%
Operating margin
6.40%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of AstraZeneca Pharma India Limited is 169.11B and its enterprise value is 165.74B. The enterprise value to revenue ratio of ASTRAZEN is 6.82. The enterprise value to EBITDA ratio of ASTRAZEN is 73.45.
The ASTRAZEN's stocks Beta value is 0.22 making it 78% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Frequently Asked Questions
1. What is AstraZeneca Pharma India Limited's Stock Symbol?
AstraZeneca Pharma India Limited trades on NSE under the ticker symbol "ASTRAZEN".
2. What is AstraZeneca Pharma India Limited's stock price today?
One share of ASTRAZEN stock can currently be purchased for approximately ₹6764.5.
3. How can I contact AstraZeneca Pharma India Limited?
AstraZeneca Pharma India Limited's mailing address is Manyata Embassy Business Park Block N1, 12th Floor Rachenahalli Outer Ring Road Bengaluru 560045 India. The company can be reached via phone at 91 80 6774 8000.
4. What is AstraZeneca Pharma India Limited's official website?
The official website of AstraZeneca Pharma India Limited is https://www.astrazeneca.in.